Percutaneous CT-Guided Renal Cryoablation: Technical Aspects, Safety, and Long-Term Oncological Outcomes in a Single Center

<i>Background and objectives:</i> Cryoablation is emerging as a safe and effective therapeutic option for treating renal cell carcinoma. This study analyzed the safety and long-term oncological outcomes of cryoablation in our center. <i>Materials and methods:</i> Patients who...

Full description

Bibliographic Details
Main Authors: Stefano Cernic, Cristina Marrocchio, Riccardo Ciabattoni, Ilaria Fiorese, Fulvio Stacul, Fabiola Giudici, Michele Rizzo, Maria Assunta Cova
Format: Article
Language:English
Published: MDPI AG 2021-03-01
Series:Medicina
Subjects:
Online Access:https://www.mdpi.com/1648-9144/57/3/291
id doaj-c662909d31f14aaab161b74e9a0a0b92
record_format Article
spelling doaj-c662909d31f14aaab161b74e9a0a0b922021-03-21T00:02:37ZengMDPI AGMedicina1010-660X1648-91442021-03-015729129110.3390/medicina57030291Percutaneous CT-Guided Renal Cryoablation: Technical Aspects, Safety, and Long-Term Oncological Outcomes in a Single CenterStefano Cernic0Cristina Marrocchio1Riccardo Ciabattoni2Ilaria Fiorese3Fulvio Stacul4Fabiola Giudici5Michele Rizzo6Maria Assunta Cova7Department of Radiology, ASUGI, Ospedale di Cattinara, 30149 Trieste, ItalyDepartment of Radiology, University of Trieste, ASUGI, Ospedale di Cattinara, 34149 Trieste, ItalyDepartment of Radiology, University of Trieste, ASUGI, Ospedale di Cattinara, 34149 Trieste, ItalyDepartment of Radiology, University of Trieste, ASUGI, Ospedale di Cattinara, 34149 Trieste, ItalyDepartment of Radiology, ASUGI, Ospedale Maggiore, 30125 Trieste, ItalyUnit of Biostatistics, Epidemiology and Public Health, Department of Cardiac, Thoracic, Vascular Sciences and Public Health, University of Padova, 35122 Padova, ItalyDepartment of Urology, University, ASUGI, Ospedale di Cattinara, 30149 Trieste, ItalyDepartment of Radiology, University of Trieste, ASUGI, Ospedale di Cattinara, 34149 Trieste, Italy<i>Background and objectives:</i> Cryoablation is emerging as a safe and effective therapeutic option for treating renal cell carcinoma. This study analyzed the safety and long-term oncological outcomes of cryoablation in our center. <i>Materials and methods:</i> Patients who underwent computed tomography (CT)-guided percutaneous cryoablation between February 2011 and June 2020 for one or more clinically localized renal tumors were identified. Technical success and treatment efficacy were assessed. Post-procedural complications were classified according to the Clavien-Dindo system. Recurrence–free survival was determined for biopsy-proven malignant renal tumors. <i>Results:</i> A total of 174 renal tumors, 78 of which were biopsy-proven malignant carcinomas, were treated in 138 patients (97 males and 41 females, mean age: 73 years, range: 43–89 years). Mean tumor size was 2.25 cm and 54.6% of the lesions required a complex approach. Technical success was achieved in 171 out of 174 tumors (98.3%). Primary treatment efficacy was 95.3% and increased to 98.2% when retreats were taken into account. The overall complication rate was 29.8%. No complications of Clavien-Dindo grade III or more were encountered. Median follow-up was 21.92 months (range: 0.02–99.87). Recurrence-free survival was 100% at 1 year, 95.3% (95% CI: 82.1%–98.8%) at 3 years, and 88.6% (95% CI: 71.8%–95.7%) at 5 years. <i>Conclusions:</i> Cryoablation is a safe and effective technique for the treatment of small renal lesions, with no major complications when performed by expert interventional radiologists. The multidisciplinary discussion is essential, especially considering the high number of histologically undetermined lesions. Our long-term oncological outcomes are encouraging and in line with the literature.https://www.mdpi.com/1648-9144/57/3/291percutaneousrenal cryoablationinterventional radiologyrenal masstechnical aspectsoutcomes
collection DOAJ
language English
format Article
sources DOAJ
author Stefano Cernic
Cristina Marrocchio
Riccardo Ciabattoni
Ilaria Fiorese
Fulvio Stacul
Fabiola Giudici
Michele Rizzo
Maria Assunta Cova
spellingShingle Stefano Cernic
Cristina Marrocchio
Riccardo Ciabattoni
Ilaria Fiorese
Fulvio Stacul
Fabiola Giudici
Michele Rizzo
Maria Assunta Cova
Percutaneous CT-Guided Renal Cryoablation: Technical Aspects, Safety, and Long-Term Oncological Outcomes in a Single Center
Medicina
percutaneous
renal cryoablation
interventional radiology
renal mass
technical aspects
outcomes
author_facet Stefano Cernic
Cristina Marrocchio
Riccardo Ciabattoni
Ilaria Fiorese
Fulvio Stacul
Fabiola Giudici
Michele Rizzo
Maria Assunta Cova
author_sort Stefano Cernic
title Percutaneous CT-Guided Renal Cryoablation: Technical Aspects, Safety, and Long-Term Oncological Outcomes in a Single Center
title_short Percutaneous CT-Guided Renal Cryoablation: Technical Aspects, Safety, and Long-Term Oncological Outcomes in a Single Center
title_full Percutaneous CT-Guided Renal Cryoablation: Technical Aspects, Safety, and Long-Term Oncological Outcomes in a Single Center
title_fullStr Percutaneous CT-Guided Renal Cryoablation: Technical Aspects, Safety, and Long-Term Oncological Outcomes in a Single Center
title_full_unstemmed Percutaneous CT-Guided Renal Cryoablation: Technical Aspects, Safety, and Long-Term Oncological Outcomes in a Single Center
title_sort percutaneous ct-guided renal cryoablation: technical aspects, safety, and long-term oncological outcomes in a single center
publisher MDPI AG
series Medicina
issn 1010-660X
1648-9144
publishDate 2021-03-01
description <i>Background and objectives:</i> Cryoablation is emerging as a safe and effective therapeutic option for treating renal cell carcinoma. This study analyzed the safety and long-term oncological outcomes of cryoablation in our center. <i>Materials and methods:</i> Patients who underwent computed tomography (CT)-guided percutaneous cryoablation between February 2011 and June 2020 for one or more clinically localized renal tumors were identified. Technical success and treatment efficacy were assessed. Post-procedural complications were classified according to the Clavien-Dindo system. Recurrence–free survival was determined for biopsy-proven malignant renal tumors. <i>Results:</i> A total of 174 renal tumors, 78 of which were biopsy-proven malignant carcinomas, were treated in 138 patients (97 males and 41 females, mean age: 73 years, range: 43–89 years). Mean tumor size was 2.25 cm and 54.6% of the lesions required a complex approach. Technical success was achieved in 171 out of 174 tumors (98.3%). Primary treatment efficacy was 95.3% and increased to 98.2% when retreats were taken into account. The overall complication rate was 29.8%. No complications of Clavien-Dindo grade III or more were encountered. Median follow-up was 21.92 months (range: 0.02–99.87). Recurrence-free survival was 100% at 1 year, 95.3% (95% CI: 82.1%–98.8%) at 3 years, and 88.6% (95% CI: 71.8%–95.7%) at 5 years. <i>Conclusions:</i> Cryoablation is a safe and effective technique for the treatment of small renal lesions, with no major complications when performed by expert interventional radiologists. The multidisciplinary discussion is essential, especially considering the high number of histologically undetermined lesions. Our long-term oncological outcomes are encouraging and in line with the literature.
topic percutaneous
renal cryoablation
interventional radiology
renal mass
technical aspects
outcomes
url https://www.mdpi.com/1648-9144/57/3/291
work_keys_str_mv AT stefanocernic percutaneousctguidedrenalcryoablationtechnicalaspectssafetyandlongtermoncologicaloutcomesinasinglecenter
AT cristinamarrocchio percutaneousctguidedrenalcryoablationtechnicalaspectssafetyandlongtermoncologicaloutcomesinasinglecenter
AT riccardociabattoni percutaneousctguidedrenalcryoablationtechnicalaspectssafetyandlongtermoncologicaloutcomesinasinglecenter
AT ilariafiorese percutaneousctguidedrenalcryoablationtechnicalaspectssafetyandlongtermoncologicaloutcomesinasinglecenter
AT fulviostacul percutaneousctguidedrenalcryoablationtechnicalaspectssafetyandlongtermoncologicaloutcomesinasinglecenter
AT fabiolagiudici percutaneousctguidedrenalcryoablationtechnicalaspectssafetyandlongtermoncologicaloutcomesinasinglecenter
AT michelerizzo percutaneousctguidedrenalcryoablationtechnicalaspectssafetyandlongtermoncologicaloutcomesinasinglecenter
AT mariaassuntacova percutaneousctguidedrenalcryoablationtechnicalaspectssafetyandlongtermoncologicaloutcomesinasinglecenter
_version_ 1724211229987176448